Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Restructuring Costs: 2024-2025

Historic Restructuring Costs for Bicycle Therapeutics (BCYC) over the last 2 years, with Sep 2025 value amounting to $2.5 million.

  • Bicycle Therapeutics' Restructuring Costs fell 2.29% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2024, which is 0.99% down from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Restructuring Costs is $2.5 million, which was up 6.27% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Restructuring Costs registered a high of $2.6 million during Q4 2024, and its lowest value of $1.9 million during Q2 2024.
  • For the 2-year period, Bicycle Therapeutics' Restructuring Costs averaged around $2.3 million, with its median value being $2.3 million (2025).
  • Data for Bicycle Therapeutics' Restructuring Costs shows a peak YoY increase of 21.45% (in 2025) and a maximum YoY decrease of 2.29% (in 2025) over the last 5 years.
  • Bicycle Therapeutics' Restructuring Costs (Quarterly) stood at $2.6 million in 2024, then decreased by 2.29% to $2.5 million in 2025.
  • Its Restructuring Costs was $2.5 million in Q3 2025, compared to $2.3 million in Q2 2025 and $2.2 million in Q1 2025.